Finance

Lists
CUV:ASX
Clinuvel Pharmaceuticals Ltd
8,14 AUD
+0,49%
(+0,040) 1D
5 ოქტ, 12:14:00 GMT+11  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for CUV...
Open
8,10 AUD
High
8,14 AUD
Low
8,05 AUD
Mkt. cap
410,48 მლნ.
Avg. vol.
164,40 ათ.
Volume
9,35 ათ.
Dividend
0,61%
Quarterly dividend
0,01 AUD
Ex-dividend date
3 სექ. 2026
P/E ratio
12,64
52-wk high
13,48 AUD
52-wk low
7,93 AUD
EPS
0,64 AUD
Shares outstanding
50,43 მლნ.
No. of employees
16
Open
8,10 AUD
High
8,14 AUD
Low
8,05 AUD
Mkt. cap
410,48 მლნ.
Avg. vol.
164,40 ათ.
Volume
9,35 ათ.
Dividend
0,61%
Quarterly dividend
0,01 AUD
Ex-dividend date
3 სექ. 2026
P/E ratio
12,64
52-wk high
13,48 AUD
52-wk low
7,93 AUD
EPS
0,64 AUD
Shares outstanding
50,43 მლნ.
No. of employees
16
News stories
From web sources and news partners
About Clinuvel Pharmaceuticals Ltd
CEOფილიპ ჯეი ვოლგენ
Employees16
Founded1987
Headquarters-
Sector-
Websiteclinuvel.com
Previous reportsAll values in AUD
Loading Previous Earnings...
Revenue
Net income
All values in AUD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
18,47 მლნ.
18,47 მლნ.
28,55 მლნ.
28,55 მლნ.
Cost of goods sold
2,28 მლნ.
2,28 მლნ.
5,62 მლნ.
5,62 მლნ.
Cost of revenue
2,28 მლნ.
2,28 მლნ.
5,62 მლნ.
5,62 მლნ.
Research and development expenses
1,70 მლნ.
1,70 მლნ.
7,35 მლნ.
7,35 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6,96 მლნ.
6,96 მლნ.
2,83 მლნ.
2,83 მლნ.
Operating expense
9,42 მლნ.
9,42 მლნ.
9,42 მლნ.
9,42 მლნ.
Total operating expenses
11,71 მლნ.
11,71 მლნ.
15,04 მლნ.
15,04 მლნ.
Operating income
6,76 მლნ.
6,76 მლნ.
13,51 მლნ.
13,51 მლნ.
Other non operating income
-
-
322,45 ათ.
322,45 ათ.
EBT including unusual items
7,29 მლნ.
7,29 მლნ.
16,54 მლნ.
16,54 მლნ.
EBT excluding unusual items
7,29 მლნ.
7,29 მლნ.
16,54 მლნ.
16,54 მლნ.
Income tax expense
2,07 მლნ.
2,07 მლნ.
4,80 მლნ.
4,80 მლნ.
Effective tax rate
28,39%
28,39%
29,03%
29,03%
Other operating expenses
-1,24 ათ.
-1,24 ათ.
1,24 ათ.
1,24 ათ.
Net income
5,22 მლნ.
5,22 მლნ.
11,74 მლნ.
11,74 მლნ.
Net profit margin
28,28%
28,28%
41,11%
41,11%
Earnings per share
-
-
-
-
Interest and investment income
2,63 მლნ.
2,63 მლნ.
3,87 მლნ.
3,87 მლნ.
Interest expense
-1,28 მლნ.
-1,28 მლნ.
-
-
Net interest expenses
1,35 მლნ.
1,35 მლნ.
3,87 მლნ.
3,87 მლნ.
Depreciation and amortization charges
250,02 ათ.
250,02 ათ.
-250,02 ათ.
-250,02 ათ.
EBITDA
7,01 მლნ.
7,01 მლნ.
13,55 მლნ.
13,55 მლნ.
Gain or loss from assets sale
-
-
28,62 ათ.
28,62 ათ.
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები